Plant ID: NPO26902
Plant Latin Name: Vigna radiata
Taxonomy Genus: Vigna
Taxonomy Family: Fabaceae
NCBI TaxonomyDB:
157791
Plant-of-the-World-Online:
n.a.
Thailand; Indonesia; India
GRM8; GRM1; | |
ADRA2B; ADORA3; HCAR2; | |
BLM; | |
GRIA4; GRIA2; GRIK3; GRIK5; GRIK1; | |
MAPK1; | |
NFKB1; | |
SLC1A1; SLCO1B1; | |
LMNA; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Ionotropic glutamate receptor | GRIA4 | Glutamate receptor ionotropic, AMPA 4 | P48058 | CHEMBL3190 |
Ionotropic glutamate receptor | GRIA2 | Glutamate receptor ionotropic, AMPA 2 | P42262 | CHEMBL4016 |
Ionotropic glutamate receptor | GRIK3 | Glutamate receptor ionotropic kainate 3 | Q13003 | CHEMBL3684 |
Ionotropic glutamate receptor | GRIK5 | Glutamate receptor ionotropic kainate 5 | Q16478 | CHEMBL2675 |
Ionotropic glutamate receptor | GRIK1 | Glutamate receptor ionotropic kainate 1 | P39086 | CHEMBL1918 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
SLC superfamily of solute carriers | SLC1A1 | Excitatory amino acid transporter 3 | P43005 | CHEMBL2721 |
SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
Small molecule receptor (family A GPCR) | ADRA2B | Alpha-2b adrenergic receptor | P18089 | CHEMBL1942 |
Small molecule receptor (family A GPCR) | ADORA3 | Adenosine A3 receptor | P0DMS8 | CHEMBL256 |
Small molecule receptor (family A GPCR) | HCAR2 | Hydroxycarboxylic acid receptor 2 | Q8TDS4 | CHEMBL3785 |
Small molecule receptor (family C GPCR) | GRM8 | Metabotropic glutamate receptor 8 | O00222 | CHEMBL3228 |
Small molecule receptor (family C GPCR) | GRM1 | Metabotropic glutamate receptor 1 | Q13255 | CHEMBL3772 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005215; transporter activity | GO:0005234; extracellularly glutamate-gated ion channel activity | 2.253E-12 | 1.226E-08 | GRIA2, GRIA4, GRIK1, GRIK3, GRIK5 |
BP | GO:0009987; cellular process | GO:0035235; ionotropic glutamate receptor signaling pathway | 1.270E-11 | 5.532E-08 | GRIA2, GRIA4, GRIK1, GRIK3, GRIK5 |
BP | GO:0023052; signaling | GO:0060079; excitatory postsynaptic potential | 2.126E-09 | 3.561E-06 | GRIA2, GRIA4, GRIK1, GRIK3, GRIK5 |
MF | GO:0005215; transporter activity | GO:0015277; kainate selective glutamate receptor activity | 4.658E-09 | 6.339E-06 | GRIK1, GRIK3, GRIK5 |
BP | GO:0009987; cellular process | GO:0007196; adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway | 3.905E-08 | 4.049E-05 | GRIK3, GRM1, GRM8 |
MF | Unclassified; | GO:0004872; receptor activity | 5.670E-08 | 5.144E-05 | ADORA3, ADRA2B, GRIA2, GRIA4, GRIK1, GRIK3, GRIK5, GRM1, GRM8, HCAR2 |
BP | GO:0023052; signaling | GO:0051966; regulation of synaptic transmission, glutamatergic | 1.390E-07 | 8.902E-05 | GRIK1, GRIK3, GRM1, GRM8 |
CC | GO:0044456; synapse part | GO:0045211; postsynaptic membrane | 5.875E-07 | 3.286E-04 | GRIA2, GRIA4, GRIK1, GRIK3, GRIK5 |
MF | GO:0005215; transporter activity | GO:0004971; AMPA glutamate receptor activity | 3.856E-06 | 1.646E-03 | GRIA2, GRIA4 |
MF | GO:0005215; transporter activity | GO:0008381; mechanosensitive ion channel activity | 5.522E-06 | 2.186E-03 | GRIA2, GRIA4, GRIK1, GRIK3, GRIK5 |
CC | GO:0044425; membrane part | GO:0008328; ionotropic glutamate receptor complex | 6.926E-06 | 2.600E-03 | GRIA2, GRIA4, GRIK5 |
BP | GO:0023052; signaling | GO:0023051; regulation of signaling | 9.666E-06 | 3.341E-03 | ADRA2B, BLM, GRIK1, GRIK3, GRIK5, GRM1, GRM8, HCAR2, LMNA, MAPK1, NFKB1 |
CC | GO:0044456; synapse part | GO:0042734; presynaptic membrane | 1.712E-05 | 5.481E-03 | GRIK5, GRM1, GRM8 |
CC | GO:0030054; cell junction | GO:0030054; cell junction | 2.563E-05 | 7.752E-03 | GRIA2, GRIA4, GRIK1, GRIK3, GRIK5, HCAR2, MAPK1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09156 Nervous system | hsa04724 | Glutamatergic synapse | 5.093E-17 | 6.010E-15 | GRIA2, GRIK5, SLC1A1, GRM8, GRIK3, MAPK1, GRIK1, GRM1, GRIA4 |
09130 Environmental Information Processing | 09133 Signaling molecules and interaction | hsa04080 | Neuroactive ligand-receptor interaction | 1.731E-13 | 1.021E-11 | GRIA2, GRIK5, ADORA3, GRM8, GRIK3, GRIK1, ADRA2B, GRM1, GRIA4 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04024 | cAMP signaling pathway | 3.706E-07 | 1.458E-05 | HCAR2, GRIA2, MAPK1, NFKB1, GRIA4 |
09150 Organismal Systems | 09156 Nervous system | hsa04723 | Retrograde endocannabinoid signaling | 1.064E-06 | 3.139E-05 | GRIA2, MAPK1, GRM1, GRIA4 |
09150 Organismal Systems | 09156 Nervous system | hsa04730 | Long-term depression | 1.398E-05 | 3.299E-04 | GRIA2, MAPK1, GRM1 |
09150 Organismal Systems | 09156 Nervous system | hsa04720 | Long-term potentiation | 1.864E-05 | 3.666E-04 | GRIA2, MAPK1, GRM1 |
09150 Organismal Systems | 09159 Environmental adaptation | hsa04713 | Circadian entrainment | 5.559E-05 | 9.371E-04 | GRIA2, MAPK1, GRIA4 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 1.759E-04 | 2.255E-03 | LMNA, MAPK1, NFKB1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04071 | Sphingolipid signaling pathway | 1.114E-04 | 1.644E-03 | ADORA3, MAPK1, NFKB1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04072 | Phospholipase D signaling pathway | 1.911E-04 | 2.255E-03 | GRM8, MAPK1, GRM1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04022 | cGMP-PKG signaling pathway | 2.956E-04 | 3.171E-03 | ADORA3, MAPK1, ADRA2B |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 9.334E-04 | 7.343E-03 | MAPK1, NFKB1 |
09160 Human Diseases | 09164 Substance dependence | hsa05033 | Nicotine addiction | 4.598E-04 | 4.521E-03 | GRIA2, GRIA4 |
09160 Human Diseases | 09164 Substance dependence | hsa05030 | Cocaine addiction | 6.903E-04 | 6.266E-03 | GRIA2, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05212 | Pancreatic cancer | 1.249E-03 | 8.182E-03 | MAPK1, NFKB1 |
09160 Human Diseases | 09164 Substance dependence | hsa05031 | Amphetamine addiction | 1.287E-03 | 8.182E-03 | GRIA2, GRIA4 |
09150 Organismal Systems | 09151 Immune system | hsa04621 | NOD-like receptor signaling pathway | 9.334E-04 | 7.343E-03 | MAPK1, NFKB1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04917 | Prolactin signaling pathway | 1.484E-03 | 8.182E-03 | MAPK1, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05220 | Chronic myeloid leukemia | 1.526E-03 | 8.182E-03 | MAPK1, NFKB1 |
09150 Organismal Systems | 09151 Immune system | hsa04662 | B cell receptor signaling pathway | 1.526E-03 | 8.182E-03 | MAPK1, NFKB1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05131 | Shigellosis | 1.212E-03 | 8.182E-03 | MAPK1, NFKB1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05140 | Leishmaniasis | 1.526E-03 | 8.182E-03 | MAPK1, NFKB1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05133 | Pertussis | 1.609E-03 | 8.257E-03 | MAPK1, NFKB1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
I00-I99: Diseases of the circulatory system | Cerebrovascular ischaemia | I61-I63 | ADORA3; |
I00-I99: Diseases of the circulatory system | Neurological disease | I21, I22, R52, R52.1-R52.2, R60.9, G89 | GRM1; GRIK1; |
I00-I99: Diseases of the circulatory system | Cardiovascular disorder | I00-I99 | HCAR2; |
C00-D49: Neoplasms | Cancer | C00-C96 | NFKB1; ADORA3; MAPK1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Huntington's disease | F02.2, G10 | GRM1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Schizophrenia | F20 | GRM1; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | ADORA3; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Alcohol use disorders | F10.2 | ADRA2B; GRIK1; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | GRM1; |
C00-D49: Neoplasms | Hepatocellular carcinoma | C22.0 | ADORA3; |
NA: NA | Hepatitis C virus infection | NA | ADORA3; |
E00-E89: Endocrine, nutritional and metabolic diseases | Hyperlipidaemia | E78 | HCAR2; |
G00-G99: Diseases of the nervous system G00-G99 | Epilepsy | G40 | GRIK1; |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | ADORA3; |
I00-I99: Diseases of the circulatory system | Acute ischemic stroke | I61-I63 | HCAR2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NFKB1; HCAR2; |
I00-I99: Diseases of the circulatory system | Ischemia | I99.8 | ADORA3; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Major depressive disorder | F32, F33, M32 | HCAR2; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MAPK1; |
I00-I99: Diseases of the circulatory system | Atherosclerosis | I70 | HCAR2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Inflammation | E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89 | ADORA3; |
G00-G99: Diseases of the nervous system G00-G99 | Parkinson's disease | G20 | GRIA2; GRIA4; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | GRM1; GRIK1; |
G00-G99: Diseases of the nervous system G00-G99 | Neuropathic pain | G64, G90.0 | GRM1; ADRA2B; GRIK1; |
I00-I99: Diseases of the circulatory system | Arteriosclerosis | I70 | HCAR2; |
I00-I99: Diseases of the circulatory system | Restenosis | I51.89 | MAPK1; |